| human | Q5 |
| P496 | ORCID iD | 0000-0002-5318-8276 |
| P1153 | Scopus author ID | 55781273100 |
| P735 | given name | Pieter | Q1237447 |
| Pieter | Q1237447 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q35822472 | "GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study". |
| Q57316510 | A comparison of lung function equipment with emphasis on interchangeability and methods |
| Q44249330 | A comparison of six software packages for evaluation of solid lung nodules using semi-automated volumetry: what is the minimum increase in size to detect growth in repeated CT examinations |
| Q35549729 | A genetic polymorphism in the CAV1 gene associates with the development of bronchiolitis obliterans syndrome after lung transplantation |
| Q57316472 | ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy |
| Q46417463 | Airway wall thickness associated with forced expiratory volume in 1 second decline and development of airflow limitation |
| Q47715921 | Alveolar volume determined by single-breath helium dilution correlates with the high-resolution computed tomography-derived nonemphysematous lung volume. |
| Q45149430 | An investigation into the predictive value of cascade impactor results for side effects of inhaled salbutamol. |
| Q33283284 | An off-line breath sampling and analysis method suitable for large screening studies. |
| Q28286971 | Analysis of SNPs with an effect on gene expression identifies UBE2L3 and BCL3 as potential new risk genes for Crohn's disease |
| Q51982692 | Analyzing bronchodilation with emphasis on disease type, age and sex. |
| Q53225541 | Association of the transfer coefficient of the lung for carbon monoxide with emphysema progression in male smokers. |
| Q34685125 | CT air trapping is independently associated with lung function reduction over time |
| Q53232777 | CT-quantified emphysema in male heavy smokers: association with lung function decline. |
| Q36310117 | Can patients use all dry powder inhalers equally well? |
| Q57316503 | Carotid angioplasty and stenting: Treatment of postcarotid endarterectomy restenosis is at least as safe as primary stenosis treatment |
| Q57316481 | Changes in disease activity, lung function and quality of life in patients with refractory sarcoidosis after anti-TNF treatment |
| Q53016329 | Chest Computed Tomography-Based Scoring of Thoracic Sarcoidosis: Inter-rater Reliability of CT Abnormalities. |
| Q42629408 | Common and different genetic background for rheumatoid arthritis and coeliac disease |
| Q30409688 | Common genes underlying asthma and COPD? Genome-wide analysis on the Dutch hypothesis |
| Q34778639 | Computed tomography structural lung changes in discordant airflow limitation |
| Q57316484 | Computed tomography-quantified emphysema distribution is associated with lung function decline |
| Q51706054 | Contribution of CT quantified emphysema, air trapping and airway wall thickness on pulmonary function in male smokers with and without COPD. |
| Q42881151 | Correction: Susceptibility to chronic mucus hypersecretion, a genome wide association study |
| Q57316490 | Corrigendum to “Reference values for paediatric pulmonary function testing: The Utrecht dataset” [Respir Med 105 (2011) 15–23] |
| Q36310112 | Could interchangeable use of dry powder inhalers affect patients? |
| Q40692512 | Cystic Fibrosis-Related Diabetes with strict glycaemic control is not associated with frequent intravenous antibiotics use for pulmonary infections. |
| Q34441746 | Defining the role of common variation in the genomic and biological architecture of adult human height |
| Q36905737 | Diagnosis of chronic obstructive pulmonary disease in lung cancer screening Computed Tomography scans: independent contribution of emphysema, air trapping and bronchial wall thickening |
| Q51950831 | Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension. |
| Q51925074 | Diffusing capacity for nitric oxide: reference values and dependence on alveolar volume. |
| Q31020997 | Discriminating asthma and COPD based on bronchodilator data: an improvement of the methods |
| Q43788275 | Discriminating dominant computed tomography phenotypes in smokers without or with mild COPD. |
| Q30361777 | Dissecting the genetics of chronic mucus hypersecretion in smokers with and without COPD. |
| Q42459473 | Distribution of emphysema in heavy smokers: impact on pulmonary function |
| Q57316506 | Durability of surgery for restenosis after carotid endarterectomy |
| Q44844176 | Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchoconstriction. |
| Q56773605 | Early identification of small airways disease on lung cancer screening CT: comparison of current air trapping measures |
| Q33450523 | Efficacy of an mHealth intervention to stimulate physical activity in COPD patients after pulmonary rehabilitation |
| Q57316524 | Equivalence testing and equivalence limits of metered-dose inhalers and dry powder inhalers measured by in vitro impaction |
| Q34734141 | Evaluation of CD103 as a cellular marker for the diagnosis of pulmonary sarcoidosis |
| Q57316478 | Evaluation of Circulating YKL-40 Levels in Idiopathic Interstitial Pneumonias |
| Q51659356 | Flow dependency and off-line measurement of exhaled NO in children. |
| Q47785386 | Flow-volumes indices as means to discriminate between intra- and extrapulmonary restrictive disease |
| Q48667584 | Follow-up of CT-derived airway wall thickness: Correcting for changes in inspiration level improves reliability. |
| Q30274832 | Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis |
| Q57316497 | Genetic polymorphisms in MMP7 and reduced serum levels associate with the development of bronchiolitis obliterans syndrome after lung transplantation |
| Q22305005 | Genetic studies of body mass index yield new insights for obesity biology |
| Q30420166 | Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction |
| Q28943403 | Genome-wide association study of coronary and aortic calcification implicates risk loci for coronary artery disease and myocardial infarction |
| Q34300307 | Genome-wide study identifies two loci associated with lung function decline in mild to moderate COPD. |
| Q30408059 | Genome-wide study of percent emphysema on computed tomography in the general population. The Multi-Ethnic Study of Atherosclerosis Lung/SNP Health Association Resource Study |
| Q54798374 | Genotype-phenotype relationship for localization and age distribution of telangiectases in hereditary hemorrhagic telangiectasia. |
| Q53194827 | Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans. |
| Q33309292 | In vitro performance testing of the novel Medspray wet aerosol inhaler based on the principle of Rayleigh break-up |
| Q46020233 | In vivo performance testing of the novel Medspray wet aerosol inhaler. |
| Q57316526 | Letter to the editors |
| Q38960675 | Long-term follow up of humoral immune status in adult lung transplant recipients |
| Q57316492 | Longitudinal change of prebronchodilator spirometric obstruction |
| Q42743958 | Low-dose CT measurements of airway dimensions and emphysema associated with airflow limitation in heavy smokers: a cross sectional study |
| Q28304797 | Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review |
| Q57316486 | Lung Function Decline in Male Heavy Smokers Relates to Baseline Airflow Obstruction Severity |
| Q45942268 | Lung cancer screening CT-based prediction of cardiovascular events. |
| Q45239775 | Markers of inflammation and oxidative stress in exacerbated chronic obstructive pulmonary disease patients |
| Q44148694 | Metal versus plastic spacers: an in vitro and in vivo comparison. |
| Q44179313 | Methotrexate vs azathioprine in second-line therapy of sarcoidosis |
| Q44217083 | New concepts for expressing forced expiratory volume in 1 s: conclusions need nuances. |
| Q57316504 | Nitric oxide diffusing capacity versus spirometry in the early diagnosis of emphysema in smokers |
| Q47614324 | No association between interleukin-18 gene polymorphisms and haplotypes in Dutch sarcoidosis patients. |
| Q57316474 | Novel Genes for Airway Wall Thickness Identified with Combined Genome-Wide Association and Expression Analyses |
| Q51971768 | Pattern of diffusion disturbance related to clinical diagnosis: The K(CO) has no diagnostic value next to the DL(CO). |
| Q51229600 | Pneumoproteins as a lung-specific biomarker of alveolar permeability in conventional on-pump coronary artery bypass graft surgery vs mini-extracorporeal circuit: a pilot study. |
| Q57316498 | Polymorphisms in innate immunity genes associated with development of bronchiolitis obliterans after lung transplantation |
| Q57316479 | Predicting an accelerated lung function decline in smokers: is there a proper threshold? |
| Q46473012 | Prediction of early cerebral outcome by transcranial Doppler monitoring in carotid bifurcation angioplasty and stenting |
| Q46211337 | Pulmonary function and CT biomarkers as risk factors for cardiovascular events in male lung cancer screening participants: the NELSON study |
| Q57316520 | Quantification of right-to-left shunt with 99mTc-labelled albumin macroaggregates and 100% oxygen in patients with hereditary haemorrhagic telangiectasia |
| Q43806334 | Randomized controlled observer-blinded treatment of chronic foot eczema with iontophoresis and bath-PUVA. |
| Q36891654 | Rate of progression of CT-quantified emphysema in male current and ex-smokers: a follow-up study |
| Q49143573 | Reduced Th2 cytokine production by sarcoidosis patients in clinical remission with chronic fatigue. |
| Q51694486 | Reduction of variability of exhaled nitric oxide in healthy volunteers. |
| Q57316522 | Reference values for alveolar membrane diffusion capacity and pulmonary capillary blood volume |
| Q34141336 | Reference values for paediatric pulmonary function testing: The Utrecht dataset. |
| Q57316511 | Relevant and Redundant Lung Function Parameters in Discriminating Asthma from COPD |
| Q57316500 | Reply to Hochheggar et al |
| Q28389796 | Response to pneumococcal vaccination in mannose-binding lectin-deficient adults with recurrent respiratory tract infections |
| Q41007032 | Sample sizes for comparative inhaled corticosteroid trials with emphasis on showing therapeutic equivalence |
| Q34071159 | Screening for emphysema via exhaled volatile organic compounds. |
| Q44219712 | Selecting the best method to evaluate bronchodilation when analysing bronchodilator studies |
| Q99559735 | Serum biomarker CA 15-3 as predictor of response to antifibrotic treatment and survival in idiopathic pulmonary fibrosis |
| Q57316488 | Spirometric Thresholds for Diagnosing COPD: 0.70 or LLN, Pre- or Post-dilator Values |
| Q48624092 | Subphenotypes of mild-to-moderate COPD by factor and cluster analysis of pulmonary function, CT imaging and breathomics in a population-based survey. |
| Q57316523 | Survival after resection of metachronous non–small cell lung cancer in 127 patients |
| Q35143045 | Susceptibility to chronic mucus hypersecretion, a genome wide association study |
| Q57316501 | Systemic and exhaled cytokine and chemokine profiles are associated with the development of bronchiolitis obliterans syndrome |
| Q48102101 | Technology use by older adults in the Netherlands and its associations with demographics and health outcomes. |
| Q52943491 | Telomere length in interstitial lung diseases. |
| Q43223136 | The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pulmonary disease is associated with emphysema |
| Q57316528 | The Characterization of Dosage Sequences of Self-Dispensing Multi-Dose Dry Powder Inhalers by Spectral Analysis and ARIMA |
| Q40096260 | The association between vitamin D and C-reactive protein levels in patients with inflammatory and non-inflammatory diseases |
| Q57316525 | The efficacy of a low-dose, monodisperse parasympathicolytic aerosol compared with a standard aerosol from a metered-dose inhaler |
| Q57316493 | The epidemiological impasse |
| Q46850256 | The interdependence between cardiovascular calcifications in different arterial beds and vascular risk factors in patients at high cardiovascular risk |
| Q57316530 | The optimal particle size for β-adrenergic aerosols in mild asthmatics |
| Q35589733 | The relationship between lung function impairment and quantitative computed tomography in chronic obstructive pulmonary disease. |
| Q37130689 | The therapeutic index of locally acting inhaled drugs as a function of their fine particle mass and particle size distribution: a literature review |
| Q47751336 | Validation of a new method to measure hydrogen peroxide in exhaled breath condensate |
| Q34562154 | Variants in the 15q24/25 locus associate with lung function decline in active smokers |
| Q36365274 | Variation in quantitative CT air trapping in heavy smokers on repeat CT examinations |
Search more.